With cases of Respiratory Syncytial Virus (RSV) on the rise this fall, Dr. Barbara Taylor, professor of infectious diseases at UT Health San Antonio, joins us for this timely episode all about RSV. Importantly, she covers the unprecedented events of the 2022-2023 season that was marred by a ‘tripledemic’ of respiratory diseases.  How do the lessons learned change the preventive approach to better protect against the deadly infection?  

Episode Highlights

0:16 Intro
0:48 The burden of RSV today
2:11 Transmission, presentation and diagnosis of RSV
4:33 Likelihood of an RSV, COVID-19, flu “triple-demic”
7:35 The history of RSV vaccine development
12:09 Risk of RSV mutation and variants
14:19 The new RSV vaccines
20:09 Spacing the RSV vaccine with other seasonal shots
22:14 Age and comorbidities as vaccine criteria
24:30 In vitro immunization
27:39 Nirsevimab and monoclonal antibodies for RSV
29:31 Using the full toolset against RSV
31:50 Yearly COVID-19 vaccine updates?
33:24 A universal flu vaccine?
37:20 Outro

Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast